Ascendis Pharma AS (ASND) — Working Capital to Net Assets Ratio
Ascendis Pharma AS (ASND) has a Working Capital to Net Assets ratio of -0.9% as of March 2026. Working capital of $-4.43 Million (current assets of $1.12 Billion minus current liabilities of $1.13 Billion) is measured against net assets of $488.48 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Ascendis Pharma AS to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Ascendis Pharma AS Working Capital to Net Assets (2011–2025)
This chart shows how Ascendis Pharma AS's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at -0.9%, reflecting working capital of $-4.43 Million against net assets of $488.48 Million USD. Check Ascendis Pharma AS tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Ascendis Pharma AS (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Ascendis Pharma AS from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Ascendis Pharma AS (ASND) total market value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -24.3% | $39.58 Million | $-162.75 Million | $1.11 Billion | $1.07 Billion | ▲ +120.4 pp |
| 2024 | -144.7% | $153.00 Million | $-105.71 Million | $1.06 Billion | $907.86 Million | ▼ -167.9 pp |
| 2023 | 23.2% | $-33.79 Million | $-145.70 Million | $702.72 Million | $736.51 Million | ▼ -55.3 pp |
| 2022 | 78.5% | $206.69 Million | $263.35 Million | $923.47 Million | $716.78 Million | ▼ -1.4 pp |
| 2021 | 79.8% | $705.53 Million | $883.63 Million | $805.89 Million | $100.36 Million | ▼ -2.1 pp |
| 2020 | 82.0% | $687.33 Million | $838.71 Million | $740.13 Million | $52.80 Million | ▼ -12.4 pp |
| 2019 | 94.3% | $563.18 Million | $597.11 Million | $611.17 Million | $47.99 Million | ▲ +3.6 pp |
| 2018 | 90.7% | $253.99 Million | $280.05 Million | $292.91 Million | $38.92 Million | ▼ -5.9 pp |
| 2017 | 96.6% | $180.87 Million | $187.21 Million | $204.63 Million | $23.77 Million | ▲ +0.1 pp |
| 2016 | 96.5% | $170.50 Million | $176.61 Million | $183.96 Million | $13.46 Million | ▲ +1.6 pp |
| 2015 | 94.9% | $114.21 Million | $120.33 Million | $125.65 Million | $11.45 Million | ▲ +6.9 pp |
| 2014 | 88.0% | $40.30 Million | $45.81 Million | $53.16 Million | $12.86 Million | ▲ +75.3 pp |
| 2013 | 12.7% | $800.00K | $6.30 Million | $21.20 Million | $20.40 Million | ▲ +215.3 pp |
| 2012 | -202.6% | $-3.15 Million | $1.56 Million | $20.70 Million | $23.85 Million | ▲ +1684.9 pp |
| 2011 | -1887.6% | $-4.40 Million | $233.00K | $17.97 Million | $22.37 Million | — |